Libertyville, IL, United States of America

William R Baker

This inventor holds 21 USPTO granted patents and 1 published patent application, primarily in Antibacterial Compounds. Top assignees: Abbott Laboratories Corporation, Pathogenesis Corporation. Active years: 1988-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William R Baker. Retrieved from https://idiyas.com/inventor/william-r-baker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 176(Granted Patents)


Location History:

  • Vernon Hills, IL (US) (1988)
  • Libertyville, IL (US) (1992 - 1996)
  • Bellevue, WA (US) (1995 - 2000)

Company Filing History:


Years Active: 1988-2000

Loading Chart...
Areas of Expertise:
Antibacterial Compounds
Renin Inhibitors
Squalene Synthase
Isoflavonoids
Nitroimidazole
Heterocyclic Peptides
Erythromycin
Diaminoalcohol
Indolo Compounds
Inhibitors
Protease
Non-Peptide
21 patents (USPTO):Explore Patents

Title: William R. Baker: Innovations in Antibiotic Development

Introduction: William R. Baker, based in Libertyville, IL, is a distinguished inventor with 21 patents to his name. His innovative contributions primarily focus on the development of compounds for combating pathogenic microbes, showcasing his dedication to advancing healthcare through biochemistry and pharmacology.

Latest Patents: Among his latest patents, Baker has developed "Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof." This invention provides methods, compounds, and compositions specifically designed for inhibiting the growth of harmful microbes in vitro and treating bacterial infections in vivo. It particularly addresses infections caused by pathogens like mycobacterial, Clostridium, Cryptosporidium, and Helicobacter through the utilization of specialized bicyclic nitroimidazole compounds.

Another significant patent is related to "Inhibitors of squalene synthase and protein farnesyltransferase." This innovative work presents a compound formula useful in inhibiting protein farnesyltransferase, which is essential for the farnesylation process of the oncogene protein Ras, and for obstructing cholesterol biosynthesis by inhibiting de novo squalene production. These research advancements are not only pivotal in drug development but also contribute significantly to therapeutic strategies in managing various diseases.

Career Highlights: Baker's career includes notable positions at leading companies such as Abbott Laboratories Corporation and Pathogenesis Corporation. His work in these institutions has allowed him to develop groundbreaking innovations, particularly in the fields of pharmacology and microbiology.

Collaborations: Throughout his career, Baker has collaborated with eminent colleagues including Anthony K. Fung and Saul H. Rosenberg. These collaborations have further enriched his research and innovations, leading to significant advancements in antibiotic development and healthcare solutions.

Conclusion: William R. Baker's commitment to innovation is evident through his extensive patent portfolio and impactful contributions to science and medicine. His pioneering work in developing novel antibacterial compounds continues to inspire future research, providing a solid foundation for improved medical therapies and public health advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…